Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Clinical Therapeutics|April 28, 2009
New chemical entities and their market penetration in Finland during the years 1996 through 2005Jaana E Martikainen, Hannes Enlund
Clinical Therapeutics|December 26, 2007
Adoption of new antiglaucoma drugs in Finland: impact of changes in copaymentJaana E Martikainen, Unto Häkkinen, Hannes Enlund
Clinical Therapeutics|August 25, 2009
Antipsychotics and antidepressants: an analysis of cost growth in Finland from 1999 to 2005Hanna Koskinen, Jaana E Martikainen, Timo Maljanen
Health Policy (Amsterdam, Netherlands)|June 3, 2021
The impact of a co-payment increase on the consumption of type 2 antidiabetics - A nationwide interrupted time series analysisHanna Rättö, Terhi Kurko, Jaana E Martikainen, et al.
European Journal of Clinical Pharmacology|April 11, 2018
Policies and availability of orphan medicines in outpatient care in 24 European countriesKati Sarnola, Riitta Ahonen, Jaana E Martikainen, et al.
Research in Social & Administrative Pharmacy : RSAP|June 30, 2019
First insight to the Finnish nationwide electronic prescription database as a data source for pharmacoepidemiology researchEmma Aarnio, Risto Huupponen, Jaana E Martikainen, et al.
Scandinavian Journal of Public Health|January 28, 2020
Gender- and age-stratified analyses of ADHD medication use in children and adolescents in Finland using population-based longitudinal data, 2008-2018Miika Vuori, Anna Koski-Pirilä, Jaana E Martikainen, et al.
Health Economics Review|June 10, 2015
The impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic medication in FinlandHanna Koskinen, Elina Ahola, Leena K Saastamoinen, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 22, 2015
Time Series Analysis on the Impact of Generic Substitution and Reference Pricing on Antipsychotic Costs in FinlandHanna Koskinen, Hennamari Mikkola, Leena K Saastamoinen, et al.
Basic & Clinical Pharmacology & Toxicology|March 13, 2018
Trends in Use of Paracetamol in the Nordic CountriesJonas W Wastesson, Jaana E Martikainen, Helga Zoëga, et al.
Pageof 3